Krystal Biotech, Inc. (KRYS) reported earnings for its fourth quarter that increased from the same period last year
The company's earnings totaled $45.5 million, or $1.52 per share. This compares with $8.7 million, or $0.30 per share, last year.
The company's revenue for the period rose 116.4% to $91.1 million from $42.1 million last year.
Krystal Biotech, Inc. earnings at a glance (GAAP) :
-Earnings: $45.5 Mln. vs. $8.7 Mln. last year.
-EPS: $1.52 vs. $0.30 last year.
-Revenue: $91.1 Mln vs. $42.1 Mln last year.
For comments and feedback: editorial@rttnews.com